Mintz Advises Relation Therapeutics on Strategic Investment From GSK
December 14, 2024
December 14, 2024
BOSTON, Massachusetts, Dec. 14 -- Mintz, a law firm, issued the following news release:
Mintz advised Relation, an industry leader in deploying computation and experimentation to drug discovery, on an equity investment of $15 million from GSK in connection with two simultaneous strategic collaborations with GSK, a global biopharma company. The collaborations are aimed at advancing the development of novel therapeutics for fibrotic diseases and osteoarthritis - conditions which affec . . .
Mintz advised Relation, an industry leader in deploying computation and experimentation to drug discovery, on an equity investment of $15 million from GSK in connection with two simultaneous strategic collaborations with GSK, a global biopharma company. The collaborations are aimed at advancing the development of novel therapeutics for fibrotic diseases and osteoarthritis - conditions which affec . . .